CJS Biotechnology Holdings ApS: Financial statements 2025
CVR: 44359065
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
CJS Biotechnology Holdings ApS (CVR 44359065) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2025 report amounted to DKK 2,253. The solvency ratio was 9.7%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 2,253
- Total Assets
- DKK 23,178
- Employees
- 0
Official annual report
How creditworthy is CJS Biotechnology Holdings ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
CJS Biotechnology Holdings ApS has published its interim report for the period October 1, 2023 to December 31, 2024.
About CJS Biotechnology Holdings ApS
CJS Biotechnology Holdings ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2023. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Christopher Savoie. The company is owned by Christopher Savoie. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2025 report amounted to DKK 2,253.